Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar QuickBen (94.95) Submitted: 7/9/2008 2:35:17 PM : Outperform Start Price: $11.37 TCM Score: -53.26

Target 6.60

Featured Broker Partners


Advertisement